The broadest mission of these Conferences is the collective pursuit of understanding of the issues surrounding screening for lung cancer, the main subissues being early diagnosis and early intervention. Any given Conference focuses on issues that are particularly topical at the time, including updates of research on and development pertaining to the practice of screening for lung cancer and related topics.
I-ELCAP has reported on the diagnostic performance of its regimen of screening for lung cancer as well as on the curability gain resulting from its consequent early diagnosis and treatment. It has also reported on alternative methods of determining the corresponding mortality reduction.
CT screening for lung cancer is a complex multi-disciplinary undertaking. The effectiveness of such a program is a function of the quality of the individual components, not only by the outcome of the program and its impact on public health, but also by the organization, implementation, execution, and acceptability of each of its components. For this reason the development of guidelines and performance indicators for a screening program is critical to maximize the benefit and minimize potential harms of the regimen of screening.